Dr. Jianzhong Shou 寿建忠
Chief Physician
Department of Urology, Cancer Hospital, Chinese Academy of Medical Sciences (National Cancer Center), Beijing
Public profile Compiled from public listings and PubMed. We do not work directly with this doctor, but we can find a specialist in this field to review your case.
Get a specialist opinionClinical focus: Diagnosis and treatment of kidney cancer, bladder cancer, and prostate cancer.
Dr. Shou graduated from Hunan Medical University in 1991 and earned a doctorate in oncology from Peking Union Medical College in 1998. The career focuses on diagnosis, surgical treatment, and pathogenesis research of urological tumors. Surgical expertise includes laparoscopic and open surgery for kidney cancer, bladder-preserving surgery, radical cystectomy, and radical prostatectomy. Dr. Shou has published over 50 articles and edited or co-edited six books.
Name order: in Chinese the family name comes first (Shou Jianzhong). Papers usually list the name as Jianzhong Shou or Shou J.
Selected publications
71 papers on PubMed matched by name and affiliation; 33 as first or senior author since 2016. Most recent first- or senior-author papers:
- Ann Med, 2026 (senior author): Clinical outcomes of metastatic non-clear cell renal cell carcinoma: a real-world single-centre experience. PubMed 41578672
- Clin Genitourin Cancer, 2026 (senior author): Prognostic Value of Preoperative Fibrinogen in Metastatic Clear Cell Renal Cell Carcinoma Patients Undergoing Cytoreductive Nephrectomy. PubMed 42919748
- Clin Genitourin Cancer, 2025 (senior author): Expression and Prognostic Significance of Different Antibody-Drug Conjugate Target Proteins in Urachal Carcinoma. PubMed 40819477
- Cell Oncol (Dordr), 2025 (senior author): Postoperative continuous saline bladder irrigation reduces active urinary cancer cells: a prospective study in NMIBC. PubMed 40299272
- Urol Oncol, 2025 (senior author): Safety and efficacy of intravesical Bacillus Calmette-Guerin instillation for superficial recurrence following bladder-sparing therapy of muscle invasive bladder cancer: A retrospective study. PubMed 39947946
- Mol Carcinog, 2025 (senior author): Predictive Value of Neutrophil Extracellular Traps in Neoadjuvant Chemotherapy for Muscle-Invasive Bladder Cancer. PubMed 39540802
- Eur Urol Open Sci, 2024 (senior author): Dynamic Changes in Serum Immunoglobulin G Predict Clinical Response and Prognosis in Metastatic Clear-cell Renal Cell Carcinoma. PubMed 39512867
- Life Sci, 2024 (senior author): Cigarette smoking-related OLC1 overexpression associated with poor prognosis in bladder urothelial carcinoma. PubMed 38880167
See the full PubMed search. Automatic matching can miss papers or include a namesake at the same hospital.
This profile has not been reviewed by the doctor. How we build this directory.
Want a specialist to review your case?
Send your records. We find a specialist in this field who can review your case and write a treatment plan with a cost estimate.
Get a specialist opinion